Your browser doesn't support javascript.
Evaluating the feasibility of performing elective gastrointestinal cancer surgery during the COVID-19 pandemic: An observational study with 60 days follow-up results of a tertiary referral pandemic hospital.
Sozutek, Alper; Seker, Ahmet; Kuvvetli, Adnan; Ozer, Nazmi; Genc, Ismail Caner.
  • Sozutek A; Division of Gastroenterological Surgery, Department of General Surgery, Adana City Training and Research Hospital, Health Sciences University, Adana, Turkey.
  • Seker A; Division of Gastroenterological Surgery, Department of General Surgery, Adana City Training and Research Hospital, Health Sciences University, Adana, Turkey.
  • Kuvvetli A; Division of Gastroenterological Surgery, Department of General Surgery, Adana City Training and Research Hospital, Health Sciences University, Adana, Turkey.
  • Ozer N; Division of Gastroenterological Surgery, Department of General Surgery, Adana City Training and Research Hospital, Health Sciences University, Adana, Turkey.
  • Genc IC; Division of Gastroenterological Surgery, Department of General Surgery, Adana City Training and Research Hospital, Health Sciences University, Adana, Turkey.
J Surg Oncol ; 123(4): 834-841, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-1070770
ABSTRACT

BACKGROUND:

The coronavirus disease 2019 (COVID-19) pandemic has interfered with the treatment algorithm for patients with gastrointestinal (GIS) cancer, resulting in deferral of surgery. We presented the outcomes of our patients to evaluate whether surgery could be safely performed and followed-up without delaying any stage of GIS cancer during the pandemic.

METHODS:

This was an observational study of 177 consecutive patients who underwent elective GIS cancer surgery between March 11 and November 1, 2020. They were assessed regarding their perioperative and 60 days follow-up results for either surgical or COVID-19 status. Morbidity was determined according to the Clavien-Dindo classification (CDC). Continuous and categorical data were presented as median ± SD and number with percentage (%), respectively.

RESULTS:

The study included 44 gastric, 33 pancreatic, 40 colon, and 59 rectal cancer patients. All patients underwent surgery and received neo/adjuvant treatments without delay. The overall morbidity (CDC grade II-IV) and mortality rates were 10.1% and 3.9%, respectively. None of the patients or medical staff were infected with COVID-19 during the study period.

CONCLUSION:

GIS cancer surgery can be safely performed even within a pandemic hospital if proper isolation measures can be achieved for both patients and health workers. Regardless of the tumor stage, surgery should not be deferred, depending on unstandardized algorithms.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Postoperative Complications / Infection Control / Gastrointestinal Neoplasms / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: J Surg Oncol Year: 2021 Document Type: Article Affiliation country: Jso.26396

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Postoperative Complications / Infection Control / Gastrointestinal Neoplasms / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: J Surg Oncol Year: 2021 Document Type: Article Affiliation country: Jso.26396